期刊文献+

MDS1-EVI1基因多态性与鼻咽癌相关性研究 被引量:1

Correlation between MDS1-EVI1 Gene Polymorphism and Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的探讨MDS1-EVI1基因SNP rs6774994多态性与云南鼻咽癌之间的相关性研究.方法采用TaqMan-PCR方法检测MDS1-EVI1基因rs6774994基因型与等位基因频率.结果 (1)鼻咽癌组和对照组MDS1-EVI1基因rs6774994各基因型(P=0.843)和等位基因频率(P=0.784)组间分布差异无统计学意义(P>0.05);(2)鼻咽癌患者MDS1-EVI1基因rs6774994,有家族遗传史患者GG基因型携带者高于无家族遗传史患者(P<0.01),且病理分化类型为非低分化鳞癌的患者GG基因型携带者高于低分化鳞癌患者(P<0.01).结论 MDS1-EVI1基因rs6774994可能不增加云南人罹患鼻咽癌的风险.MDS1-EVI1基因rs6774994GG等位基因可能与家族遗传史和病理分化类型有一定相关性. Objective To investigate the correlation of MDS1-EVI1 gene polymorphism rs6774994 with nasopharyngeal carcinoma in Yunnan population. Methods The allele frequencies of the genotypes of rs6774994 were detected by utilizing real-time fluorescent PCR method based on TaqMan probe. Results (1) There was no significant difference in the genotypes (P = 0.843) and allele frequency (P = 0.784) of MDS1-EVI1 rs6774994 between the nasopharyngeal carcinoma group and the control group (P 〉 0.05) . 2) In nasopharyngeal carcinoma patients with MDS1-EVI1 rs6774994, the GG genotype of patients with a family history was significantly higher than that of patients with no family history (P 〈0.001) , and the GG genotype of patients with no poorly-differentiated squamous cell carcinoma was significantly higher than that of patients with poorly-differentiated squamous cell carcinoma (P 〈0.001) Conclusion MDS1-EVI1 rs6774994 may be not associated with nasopharyngeal carcinoma in Yunnan population. The GG alleles with MDS1-EVI1 rs6774994 may be related to family history of genetic and pathological differentiation type.
作者 陈灿 蒋永新
出处 《昆明医科大学学报》 CAS 2013年第6期85-89,共5页 Journal of Kunming Medical University
基金 云南省科技厅-昆明医科大学联合专项基金资助项目(2009CD) 昆明医科大学研究生创新基金资助项目(2012N03)
关键词 鼻咽癌 MDS1-EVI1基因 多态性 TaqMan-PCR Nasopharyngeal carcinoma MDS1-EVI1 gene Polymorphism TaqMan-PCR
  • 相关文献

参考文献17

  • 1NUCIFORA G. The Evil gene in myeloid leukemia[J]. Leukemia, 1997,11 (12) :2 022-2 031.
  • 2NUCIFORA G,ROWLEY J D.AML1 and the 8 ;21 and 3; 21 translocations in acute and chronic myeloid leukemia [J]. Blood, 1995,86(1) : 12- 14.
  • 3METAIS J Y, DUNBAR C. The MDS1-EVI1 gene compl- ex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy [ J ]. Mol Ther, 2008, 16 ( 3 ) : 439-449.
  • 4LOPINGCO M C ,PERKINS A S. Molecular Analysis orE- vii, a zinc finger oncogene involved in myeloid leukemia [ J ]. Curr Top Microbiol Immunol, 1996,211:211 - 222.
  • 5WIESER R. The oncogene and developmental regulator E- VIl: expression, biochemical properties,and biological functions [ J ]. Gene, 2007,396 (2) : 346- 357.
  • 6BUONAMICI S, CHAKRABORTY S,SENYUK V,NUCI- FORA G. The role of EVIl in normal and leukemic cells [J]. Blood Cells Mol Dis,2003,31 (2):206-212.
  • 7NUCIFORA G, BEGY C R, KOBAYASHI H, et al. Consi- stent intergenic splicing and production of multiple tran- scripts between AML at 21q22 and unrelated genes at 3q26 in (3;21) (q26;q22) translocations [J]. Proc Nat/ Acad Sci U S A, 1994,91(9):4 004-4 008.
  • 8FEARS S, MATHIEU C, ZELEZNIKLE N, et al. Interge- nic splicing of MDS1 and Evil occurs in normal tissues as well as in myeloid leukemiaand produces a new member of the PR domain family[ J ].Proc Natl Aead Sci U S A, 1996 , 93(4) :1 642-1 647.
  • 9PETERS P, WLODARSKA I, BAENS M, et al.Fusion of E- TV 6 to MDS1/Evil as a result oft (3;12)(q26 ;p13) in myeloproliferative disorders [J ]. Cancer Res, 1997,57 : 564-569.
  • 10ZENT C, KIM N, HIEBERT S, et al. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3 ; 21 translocation : expression of co2existing multiple chimeric genes with similar functions as transcriptional repressor, but with opposite tumorigenic properties [ J ]. Curr Top Mi- crobiol Immunol, 1996,211 : 243-252.

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部